Lilly Slashes Revenue Forecasts For 2010 And 2011 Due To Health Care Reform
The drug maker blames changes to various government programs for revenue that will drop by hundreds of millions of dollars.
The drug maker blames changes to various government programs for revenue that will drop by hundreds of millions of dollars.